Objective Although the diagnostic utility of serum IgG antibodies to Helicobacter pylori (H. pylori) is well established, the usefulness of IgA-based tests is less well documented. The aim of this study was to evaluate two commercially available ELISAs, both for IgG and IgA.
Introduction
Serological tests are commercially available, easy to perform, and inexpensive and therefore have been recommended for the diagnosis of Helicobacter pylori (H. pylori) infection (1) . Many serological tests, mainly immunoglobulin G (IgG) based, have been validated against invasive methods (2) . The IgG antibody level to H. pylori is usually increased and may, in assays using specific antigens, be a marker for H. pylori infection (3) . Because the serum IgG test has shown high sensitivity and specificity, the serology test has been used widely in epidemiologic studies (4, 5) . Unlike tests that rely on bacterial urease activity, antibody tests can be performed in patients taking proton pump inhibitors or antibiotics but are not generally useful in the immediate follow-up after eradication therapy (3, 6, 7) . Most of these studies have reported a drop in titer at six months of approximately 40-50% from pretreatment levels in patients in whom the bacteria was eradicated (3, (6) (7) (8) (9) .
Serum antibodies to H. pylori, IgG, IgA, and less frequently, to IgM classes, are detected in infected individuals (10) . IgM antibodies can be detected shortly after the infection is acquired, but IgA and IgG titers indicate chronic infection (11) . Although the diagnostic utility of serologic detection of IgG antibodies to H. pylori is well established, the usefulness of IgA-based tests is less well documented. Kosunen et al (10) have described a subset of H. pylori infected patients who are positive for IgA but negative for IgG antibodies to H. pylori, making the evaluation of IgA titers the only method of serologic confirmation of treatment. The aim of this study was to evaluate two commercially available ELISAs, both for IgG and IgA, for the diagnosis of H. pylori infection.
tients who underwent upper endoscopy for the evaluation of symptoms suggestive of upper gastrointestinal tract disease were evaluated. The patients were 19 to 85 years old (121 women and 62 men), with a median age of 57.7 years. Patients were excluded if they had previously been treated for H. pylori, had undergone previous gastroduodenal surgery, or had used a proton pump inhibitor, antibiotics, or bismuth compounds within the previous month.
Endoscopy
After obtaining informed consent, routine upper endoscopy was performed in the usual manner under local pharyngeal anesthesia with the patient lying in a left lateral position. Two antral biopsies were taken from within 3 cm of the pylorus. One antral biopsy was placed in a rapid urease test (RUT, PyloriTek test, Serim Research Corp., Elkhart, IN), the remaining biopsy specimen was fixed with 10% formalin for histologic examination with Giemsa stain. The extension of intestinal metaplasia was judged by dye endoscopy with methylene blue solution. After conventional observation, 20 ml of a 0.5% solution of methylene blue was sprayed on the entire gastric mucosa. Two minutes after the application of methylene blue, approximately 50 to 100 ml of tap water was vigorously sprayed on the gastric mucosa to wash off excess dye. Positive staining which reflected the presence of the columnar mucosa with intestinal metaplasia was defined as blue staining of noneroded mucosa that persisted despite vigorous water irrigation.
A patient was considered to be infected with H. pylori when either of two biopsy tests (RUT and histology) was positive, and considered to be noninfected when both tests gave concordant negative results. 
Results
Of 183 patients, 101 were H. pylori positive and 82 were H. pylori negative by using the results of the biopsy tests as the "gold standard". The average age of those infected by the organism was 59.0 years, whereas that for the noninfected individuals was 56.2 years. Among 101 H. pylori-infected patients, both RUT and histology were positive in 90 patients. The remaining 11 patients were found to have H. pylori infection by RUT alone (n=6) or by histology alone (n=5). Peptic ulcer diseases were detected in 20 patients (14 gastric ulcers, six duodenal ulcers); all of them were H. pylori infected. Two of the infected patients had gastric cancers.
Summary of individual results is shown in Tables 1 and 2 . In 81 of 101 H. pylori-infected patients, all the tests provided the positive results (Table 1) , whereas in only 33 of 82 noninfected patients all four tests were negative (Table 2) . Discrepancy between PP-CAP IgA and HM-CAP IgG was found in 27 of 160 patients (16.9%) when patients with at Of eight noninfected patients in whom intestinal metaplasia was found by dye endoscopy, PP-CAP IgA results were positive in three of five patients with a HM-CAP IgG negative result and EIAgen IgA was detected in one of four patients with an EIAgen IgG negative result (Table 4) .
Discussion
Serology is the noninvasive technique of choice to detect H. pylori infection because it is simple, widely available, and inexpensive. The reported sensitivity and specificity of IgG serology is highly variable, ranging from 30% to 100% (12) (13) (14) . The HM-CAP IgG, evaluated in our study, had a sensitivity, specificity, positive predictive value, and negative predictive value of 94.7, 88.0, 90.9, and 93.0%, respectively. These values were very similar to those of EIAgen IgG. False-positive results of HM-CAP IgG and EIAgen IgG were obtained in 9 patients. When we compared the sensitivity and specificity of serology against biopsy-based methods such as histology and rapid urease test, defined as the gold standard, failure of the biopsy methods to detect the organism may decrease the serological true-positives and increase the false-positives. False-negative biopsies could occur when the active site of infection was missed because of the patchy distribution of H. pylori in the stomach. Multiple biopsy specimens from different areas of the stomach may reduce sampling errors. In contrast, patients who have had a previous infection with H. pylori and whose antibody levels were still elevated may have a negative histology and a positive result of serology. Despite the presence of serum antibodies, failure to detect H. pylori in biopsy specimens could have been due to atrophy or intestinal metaplasia of gastric mucosa (14, 15) . It has already been reported that this may be a major problem in the elderly (16) . Some elderly patients with a negative IgG result may have been infected previously and seroreversion may occur, reflecting that the organism have been eradicated spontaneously by the progression of atrophic gastritis and intestinal metaplasia. Based on these viewpoints, dye endoscopy was performed to evaluate the presence of intestinal metaplasia which was considered to relate to H. pylori infection.
Intestinal metaplasia was found significantly more often in the H. pylori-positive group than in the H. pylori-negative group. Japanese previous reports (17, 18) indicated that the prevalence of IgG antibodies to H. pylori was lower in the elderly people compared with those less than 40 years of age. It has been unclear whether the low prevalence of IgG antibodies to H. pylori in the elderly reflects spontaneous eradication of the organism. Miwa H et al (19) demonstrated insufficient diagnostic accuracy of imported serological kits for H. pylori infection in the Japanese population. However, several studies even in Western countries reported that the accuracy of serological tests in the elderly is unsatisfactory (16) .
On the other hand, several studies supporting the clinical utility of IgA serology have appeared. Two studies have noted few patients with confirmed H. pylori infection and with only IgA antibodies (20, 21) . Aromaa A et al (22) reported that IgA antibodies and low levels of pepsinogen I increase the risk of gastric carcinoma. In addition, IgA antibodies may appear earlier than IgG antibodies in patients who become reinfected (8, 22) .
While the sensitivity of all four tests was good the present study, with values above 92%, specificity was very low for the two IgA-based tests. In general, one can expect an IgA ELISA to have lower sensitivity values than an IgG ELISA because most individuals exhibit a predominantly IgG immune response to infection with H. pylori (23) . However, some investigators have found that about 2% of patients produce an IgA response in the absence of an IgG response (10, 20) . Furthermore, Jaskowski et al (24) showed a higher frequency of IgA-positive IgG-negative patients (38/824 cases; 7.2%) with gastrointestinal disorders suggestive of H. pylori infection. It is suggested that H. pylori infection is excluded by the clinician in the majority of these infected patients solely on the basis of a negative IgG serology result. In our population, three (3.0%) of 101 infected patients was IgA positive and IgG negative. Of eight noninfected patients in whom intestinal metaplasia was found by dye endoscopy, PP-CAP IgA and EIAgen IgA results were positive in three of five patients with a HM-CAP IgG negative result and in one of four patients with an EIAgen IgG negative result, respectively. Since positive serology results are evidence of contact with H. pylori but do not necessarily indicate current infection, determination of IgA is informative for such cases. Furthermore the prevalence of atrophic gastritis and intestinal metaplasia is very high in H. pylori positive Japanese (17) . In conclusion, great care should be taken not to underestimate the prevalence of H. pylori infection from the sesults of IgG serology in clinical practice. 
